Actions

No actions available.

Full Text of this Amendment

SA 1052. Mr. CORKER submitted an amendment intended to be proposed by him to the bill S. 1082, to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes; which was ordered to lie on the table; as follows:

At the appropriate place, insert the following:
``SEC. __. PROHIBITION ON COMMINGLING.
``(a) In General.--Notwithstanding any other provision of this Act (or an amendment made by this Act) a registered importer shall not commingle a prescription drug imported into the United States under this Act (or amendment) with another prescription drug, regardless of whether such other drug is a domestic prescription drug or a prescription drug from a permitted country.
``(b) Label.--A registered importer (including an Internet pharmacy) that dispenses a prescription drug imported from a permitted country shall affix on each dispensed container of the prescription drug the label required under subsection (c), unless such a label is already affixed to the container.
``(c) Requirements.--Each prescription drug imported under this Act (or an amendment made by this Act) shall be in a container that bears a label stating, in prominent and conspicuous type--
``(1) the following statement: `This drug has been imported from __XXXX.' with the name of the permitted country from which the prescription drug has imported in the blank space; and

``(2) that the container complies with any other applicable requirement of this Act.''.

(As printed in the Congressional Record for the Senate on May 7, 2007.)